Related Experiment Video
Updated: Mar 10, 2026

06:05
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
4.5K
Mitochondrial Replacement Techniques: Who are the Potential Users and will they Benefit?
Bioethics
|December 16, 2016
Summary
Mitochondrial replacement techniques (MRTs) offer hope for preventing genetic disorders but public discourse overlooks complex user needs. Further research is vital for equitable access to this reproductive technology.
Area of Science:
- Reproductive Biology
- Bioethics
- Genetics
Background:
- The UK legalized mitochondrial replacement techniques (MRTs) in 2015, enabling three-parent IVF to prevent mitochondrial disorders.
- MRTs involve using genetic material from three individuals to create an embryo, aiming to prevent transmission of maternally inherited conditions.
Purpose of the Study:
- To analyze the gap between public discourse on MRTs and the lived experiences of families affected by mitochondrial disorders.
- To highlight the complex reproductive choices and unmet needs of potential MRT beneficiaries.
Main Methods:
- Qualitative study exploring reproductive choices in families with mitochondrial disorders.
- Analysis of public debates surrounding MRTs, contrasting claims with expert and patient insights.
Main Results:
- Public debates oversimplified MRTs as a universal solution, obscuring potential limitations and user complexities.
- Families face intricate decisions regarding reproductive technologies, with their specific needs often remaining invisible.
Conclusions:
- There is a need for improved public information regarding MRTs.
- Intensified critical empirical research is required to address the specific needs of future beneficiaries of advanced reproductive biotechnologies.
Keywords:
beneficiariesbiotechnologiesdebatesempirical researchfuture usersmitochondrial donationpatientsMore Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
9.8K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.8K
Gene Therapy
27.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.9K
Electron Transport Chain: Complex I and II
19.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
Mitochondria
21.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.1K
Bone Marrow Sampling and Transplants
2.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.1K

